HOME >> BIOLOGY >> NEWS
Slow but sure -- Burned forest lands regenerate naturally

CORVALLIS, Ore. -- A new study of forest lands that burned in the 1990s in northern California and southwestern Oregon has concluded there is a "fair to excellent" chance that an adequate level of conifers will regenerate naturally, in sites that had no manual planting or other forest management.

The research, to be published Wednesday in the Journal of Forestry by scientists from Oregon State University, examined the recovery of conifers on 35 plots that had burned in wildfires from 9 to 19 years ago, and generally found a high level of naturally-regenerating tree seedlings.

Although the abundance of natural regeneration appeared to be variable and growth often slow, there was no evidence of recent conifer mortality or suppression leading to seedling death.

Total conifer density and the types of tree species varied quite a bit depending on elevation, but the density of surviving conifer seedlings was as much or more than typical densities in 60-100 year old stands in this region, which is about 100 to 1,000 trees per acre. Traditional old growth forests of this region, with trees 250 or more years old, often had as few as 20-40 large trees per acre.

About 10 percent of the plots studied already had larger trees that were considered "free to grow" by forestry standards. The scientists said the height of competing shrubs had "quite likely" slowed after one or two decades, and "we predict that conifer mortality will remain low and height growth will accelerate as individuals continue to emerge above the shrub layer." The study also showed that trees would regenerate at considerable distances from seed sources.

"The natural regeneration on many of these sites is actually much higher than needed to restore a forest," said Jeff Shatford, a senior faculty research assistant in the OSU Department of Forest Science. "We expect that the high density of young trees we observed will thin out naturally over time."

'"/>

Contact: Jeff Shatford
jeff.shatford@oregonstate.edu
541-737-5897
Oregon State University
4-Apr-2007


Page: 1 2 3 4

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Tropical insects go the distance to inform rainforest conservation
3. Rain forest protection works in Peru
4. Smithsonian scientists show differing patterns of rainforest biodiversity
5. Lost forest yields several new species
6. Increase in creeping vines signals major shift in southern US forests
7. Loss of hemlocks will affect water dynamics in southern Appalachian forests
8. Greenlands ancient forests shed light on stability of ice sheet
9. Northern forests less effective than tropical forests in reducing global warming
10. The kapok connection -- Study explains rainforest similarities
11. Human activities increasing carbon sequestration in forests

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Slow but sure Burned forest lands regenerate naturally

(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... October 14, 2014 – High doses of fish oil supplements, ... a common type of irregular heartbeat in which the heart ... results of the AFFORD trial led by the Montreal Heart ... College of Cardiology on October 7th. , For the ... therapy were randomly assigned to 4 grams of fish oil ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: